SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹19 Cr | ₹23 Cr | ₹14 Cr | ₹105 Cr | ₹102 Cr |
What is the latest Total Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹105 Cr |
| Mar2022 | ₹102 Cr |
How is Total Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | -20.16 | |
| Mar2025 | ₹23 Cr | 73.76 | |
| Mar2024 | ₹14 Cr | -87.13 | |
| Mar2023 | ₹105 Cr | 2.75 | |
| Mar2022 | ₹102 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹8,769.1 Cr | 4.5% | -6.2% | 9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | 4.5% |
-6.2% |
9.1% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses